rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Sarabjit Kour Nangra

Rediff.com  »  News  »   Sarabjit Kour Nangra

  News for Sarabjit Kour Nangra

  • Business

Infosys bets on new services to push sales to $20 bn by 2020

Infosys has been making bets on automation and other high-margin services like artificial intelligence to regain some ground Infosys Ltd, India's second-largest software services exporter, on......

Strong dollar dents Indian IT companies' revenues

The dollar's biggest quarterly rise against other major currencies since 2008 has undermined sales of India's IT services firms in non-U.S. markets, including Europe, in what was already a......

Sensex marks lowest close in 10 weeks; power trips, IT, auto up

The 30-share Sensex ended 50 points lower at 28,112 and the 50-share Nifty declined 12 points to close at 8,531. Markets ended lower for the sixth straight session, amid volatile trades, as......

Drugs of 7 Indian pharma firms in EMA's suspension list

Several drugs manufactured and marketed by as many as seven Indian generic pharmaceutical companies have been recommended for suspension by the European Medicines Agency (EMA) in its orders issued......

Rouble fall to impact Indian pharma exports

Though the fall in the Russian currency means earning of more roubles, the actual value of revenue will be determined only in correlation with the dollar and the rupee, according to him. The......
  Web results for Sarabjit Kour Nangra
Dr Reddy's initiates recall of two drugs in US

A year after the last recall of its generic hypertension drug Metroprolol, Hyderabad-based Dr Reddy's Laboratories Limited has initiated a... ...

http://wap.business-standard.com/article/companies/dr-reddy-s-initiates-recall-off-two-drugs-in-us-115062900792_1.html
Sarabjit Kour Nangra

In an interview with ET Now, Sarabjit Kour Nangra from Angel Broking expresses her outlook on lower revenue trends indicated by Tech Mahindra and... ...

http://economictimes.indiatimes.com/opinion/interviews/tech-mahindra-and-many-small-caps-have-indicated-trend-of-lower-revenue-for-q1-sarabjit-kour-nangra/articleshow/47862492.cms
Gujarat pharma companies focus on OTC herbal products

AHMEDABAD: Leading drug makers from the state are turning to plant extracts. Gujarat based companies, primarily engaged into manufacturing of... ...

http://timesofindia.indiatimes.com/articleshow/47827736.cms
Lupin readies Rs 7,500 crore war chest

Board gives approval to raise funds for future acquisitions, co reported to have bid for UCB SA's US generic-drug business estimated at about $1... ...

http://www.dnaindia.com/money/report-lupin-readies-rs-7500-crore-war-chest-2098333
AstraZeneca rallies over 37% in June on Forxiga launch; more gains likely

MUMBAI: Shares of AstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41... ...

http://economictimes.indiatimes.com/markets/stocks/news/astrazeneca-rallies-over-37-in-june-on-forxiga-launch-more-gains-likely/articleshow/47781168.cms

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z